Глобальная карта > Инновации > North America and Caribbean > United States > San Diego > CalciMedica
CalciMedica
CalciMedica is investigating the use of CM4620-IE in patients with severe COVID-19 pneumonia who are at risk for progression to acute respiratory distress syndrome (ARDS)